NIH and Santhera Announce Positive Results of Study with SNT-MC17/idebenone in Friedreich's Ataxia (FRDA) (available in English only)

November 13, 2006 02:00 ET | Source: Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG

For release content, please refer to the attachment.